Literature DB >> 1469058

Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition.

Q He1, J Lesley, R Hyman, K Ishihara, P W Kincade.   

Abstract

We previously found that the CD44 glycoprotein on some lymphocytes can mediate adhesion to hyaluronate (HA) bearing cells. However, many questions remain about the molecular heterogeneity of CD44 and mechanisms which control its recognition of this ligand. In vitro mutagenesis and DNA sequencing have now been used to investigate the importance of the membrane proximal region of murine CD44 for recognition of soluble or cell surface HA. CD44 with an 83 amino acid deletion in this region mediated binding to soluble ligand and the apparent avidity increased markedly in the presence of a particular antibody to CD44, IRAWB14. The shortened CD44 was however inefficient in mediating adhesion of transfected cells to HA immobilized on cell surfaces. Four new murine isoforms of CD44 were isolated from a carcinoma line by use of the polymerase chain reaction. Only two of them correspond to ones recently discovered in rat and human cells. The longest variant nearly doubled the length of the extracellular portion of the molecule and introduced an additional 20 potential sites for glycosylation. When expressed on T lymphoma cells, all four of the new murine CD44 isoforms were capable of mediating adhesion to HA bearing cells. This result contrasts with a report that a related human CD44 isoform lacks this ability when expressed on B lineage lymphoma cells. The new murine isoforms also conferred the ability to recognize soluble HA and were very responsive to the IRAWB14 antibody. A brief survey of normal murine cell lines and tissues revealed that the hemopoietic isoform was the most abundant species. These findings indicate that the NH2-terminal portion of CD44 is sufficient for HA recognition and that this function is not necessarily abrogated by variations which occur in the membrane proximal domain. They add to the known molecular diversity of CD44 and provide another experimental model in which isoform specific functions can be investigated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1469058      PMCID: PMC2289747          DOI: 10.1083/jcb.119.6.1711

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  42 in total

1.  Affinity modulation of the alpha IIb beta 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor.

Authors:  T E O'Toole; J C Loftus; X P Du; A A Glass; Z M Ruggeri; S J Shattil; E F Plow; M H Ginsberg
Journal:  Cell Regul       Date:  1990-11

2.  The complex CD44 transcriptional unit; alternative splicing of three internal exons generates the epithelial form of CD44.

Authors:  D L Cooper; G Dougherty; H J Harn; S Jackson; E W Baptist; J Byers; A Datta; G Phillips; N R Isola
Journal:  Biochem Biophys Res Commun       Date:  1992-01-31       Impact factor: 3.575

3.  Growth characteristics and drug responses of a murine lung carcinoma in vitro and in vivo.

Authors:  T Kaneko; G A LePage
Journal:  Cancer Res       Date:  1978-07       Impact factor: 12.701

4.  The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells.

Authors:  I Stamenkovic; A Aruffo; M Amiot; B Seed
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

5.  Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis.

Authors:  K Miyake; I L Weissman; J S Greenberger; P W Kincade
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

6.  Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.

Authors:  S Jalkanen; M Jalkanen
Journal:  J Cell Biol       Date:  1992-02       Impact factor: 10.539

7.  Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.

Authors:  K Miyake; C B Underhill; J Lesley; P W Kincade
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

8.  Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.

Authors:  G J Dougherty; P M Landorp; D L Cooper; R K Humphries
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

9.  Lateral diffusion of an 80,000-dalton glycoprotein in the plasma membrane of murine fibroblasts: relationships to cell structure and function.

Authors:  K Jacobson; D O'Dell; J T August
Journal:  J Cell Biol       Date:  1984-11       Impact factor: 10.539

10.  Distinct effects of two CD44 isoforms on tumor growth in vivo.

Authors:  M S Sy; Y J Guo; I Stamenkovic
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  33 in total

1.  Growth as a solid tumor or reduced glucose concentrations in culture reversibly induce CD44-mediated hyaluronan recognition by Chinese hamster ovary cells.

Authors:  Z Zheng; R D Cummings; P E Pummill; P W Kincade
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  CD44 isoform expression follows two alternative splicing pathways in breast tissue.

Authors:  X Roca; J L Mate; A Ariza; A M Muñoz-Mármol; C von Uexküll-Güldeband; I Pellicer; J J Navas-Palacios; M Isamat
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

Review 3.  Forms and functions of CD44.

Authors:  G Borland; J A Ross; K Guy
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

4.  CD44-stimulated dendrite formation ('spreading') in activated B cells.

Authors:  L Santos-Argumedo; P W Kincade; S Partida-Sánchez; R M Parkhouse
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

Review 5.  Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Authors:  Suniti Misra; Paraskevi Heldin; Vincent C Hascall; Nikos K Karamanos; Spyros S Skandalis; Roger R Markwald; Shibnath Ghatak
Journal:  FEBS J       Date:  2011-03-25       Impact factor: 5.542

Review 6.  CD44 and the adhesion of neoplastic cells.

Authors:  Z Rudzki; S Jothy
Journal:  Mol Pathol       Date:  1997-04

7.  Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor.

Authors:  Shibnath Ghatak; Vincent C Hascall; Roger R Markwald; Suniti Misra
Journal:  J Biol Chem       Date:  2010-03-03       Impact factor: 5.157

8.  Expression of CD44 variants in human inflammatory synovitis.

Authors:  L P Hale; B F Haynes; S S McCachren
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

Review 9.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

Review 10.  CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation.

Authors:  M Zöller
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.